(Q45171050)

10 December 2017

title

Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling (English)

1 reference

10 December 2017

1

Randall C Starling

1 reference

10 December 2017

Joshua M Hare

2

1 reference

10 December 2017

Paul Hauptman

3

1 reference

10 December 2017

Kenneth R McCurry

4

1 reference

10 December 2017

Hartmut W Mayer

5

1 reference

10 December 2017

John M Kovarik

6

1 reference

10 December 2017

Heinz Schmidli

7

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

American Journal of Transplantation

10 December 2017

published in

1 reference

10 December 2017

volume

4

1 reference

10 December 2017

issue

12

1 reference

10 December 2017

page(s)

2126-2131

1 reference

Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

Cardiac allograft vasculopathy: prevention and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

The role of vitronectin receptor (alphavbeta3) and tissue factor in the pathogenesis of transplant coronary vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

The role of Certican (everolimus, rad) in the many pathways of chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

Impact of intravascular ultrasound in understanding transplant coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

Exposure-response relationships for everolimus in de novo kidney transplantation: defining a therapeutic range

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

Early clinical experience with a novel rapamycin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

Chronic renal failure after transplantation of a nonrenal organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1600-6143.2004.00601.X

10.1046/J.1600-6143.2004.00601.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference